Expression and prognostic significance of MAP4K4 in lung adenocarcinoma

This publication has 23 references indexed in Scilit:

• TKTL-1 expression in lung cancer
  Pathology - Research and Practice, 2012
• Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients
  Lung Cancer, 2011
• Do all lung adenocarcinomas follow a stepwise progression?
  Lung Cancer, 2011
• Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification
  Journal of Thoracic Oncology, 2011
• Geminin expression in small lung adenocarcinomas: Implication of prognostic significance
  Lung Cancer, 2011
• ShRNA-Targeted MAP4K4 Inhibits Hepatocellular Carcinoma Growth
  Clinical Cancer Research, 2011
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
  Journal of Thoracic Oncology, 2011
• Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival
  Cancer, 2009
• Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
  Clinical Cancer Research, 2008
• A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase
  Proceedings of the National Academy of Sciences, 2006